Bio Protocol vs Gala — how do they compare? Bio Protocol trades at Rp516.9 (market cap Rp1,15T, Rp264,79M 24h volume), while Gala trades at Rp36.94 (market cap Rp1,8T, Rp488,12M 24h volume). The key difference: Gala is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 48,8B / 50B GALA (98%) for Gala. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Gala for 89 Days on average.
| BIO | GALA | |
|---|---|---|
Market Cap | Rp1,15T | Rp1,8T |
Volume (24h) | Rp264,79M | Rp488,12M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 48,8B / 50B GALA (98%) |
Typical Hold Time | 16 Days | 89 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
GALA is currently trading at Rp36.713 with a bearish technical signal, showing oversold conditions on short-term RSI but facing strong selling pressure from moving averages. The token is near full circulation at 98% with 48.8M of 50M GALA in supply. Price action is testing key support levels at Rp35-36 while resistance sits at Rp38-39. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with potential for short-term bounce from oversold levels, but the bearish trend and lack of fundamental catalysts suggest continued pressure. Key opportunities include oversold technical conditions, while major risks involve low liquidity, crypto market volatility, and the absence of recent ecosystem developments to drive adoption.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Gala Games (GALA) aims to take the gaming industry in a different direction by giving players back control over their games. Gala Games mission is to make “blockchain games you’ll actually want to play.”
Read more on GALA →